Continuous glucose monitors on the rise after FDA approval

Continuous glucose monitors (CGMs) have been gaining popularity among diabetics in recent years, and their use is expected to increase even more now that the U.S. Food and Drug Administration (FDA) has approved the use of these devices for people with diabetes.

CGMs are small wearable devices that continuously monitor blood glucose levels throughout the day and night. This technology provides real-time data on blood sugar levels, allowing individuals with diabetes to better manage their condition and make more informed decisions about their diet, exercise, and medication.

The FDA’s approval of CGMs for use in people with diabetes is a significant milestone for the diabetes community. Previously, CGMs were only approved for use in people with type 1 diabetes, but now they can be used by individuals with type 2 diabetes as well. This means that millions of people with diabetes now have access to this life-changing technology.

One of the main benefits of CGMs is that they eliminate the need for frequent finger pricks to check blood sugar levels. Instead, the device continuously monitors glucose levels and alerts the user if their levels are too high or too low. This can help prevent dangerous fluctuations in blood sugar and reduce the risk of long-term complications associated with diabetes.

Another advantage of CGMs is that they provide a more comprehensive view of blood sugar patterns over time. By tracking glucose levels throughout the day and night, individuals with diabetes can identify trends and make adjustments to their treatment plan as needed. This can lead to better control of blood sugar levels and improved overall health outcomes.

CGMs have also been shown to help reduce the risk of hypoglycemia (low blood sugar) and hyperglycemia (high blood sugar) in people with diabetes. By providing real-time data on glucose levels, these devices can help individuals make more timely decisions about their insulin dosing and dietary choices, ultimately leading to better blood sugar management.

Overall, the approval of CGMs for use in people with diabetes is a positive development that is expected to have a significant impact on the way diabetes is managed. With these devices becoming more accessible and affordable, more individuals with diabetes will have the opportunity to take control of their condition and live healthier, more fulfilling lives.

Scroll to Top